Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China
Saved in:
| Published in: | Lung Cancer: Targets and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301674994892804 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Lung Cancer: Targets and Therapy |
| description | |
| discipline_display | Respiratory Diseases |
| discipline_facet | Respiratory Diseases |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:58413 |
| institution | FRELIP |
| journal_source_facet | Lung Cancer: Targets and Therapy |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China Respiratory Diseases General Respiratory Diseases |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Respiratory Diseases General Respiratory Diseases Respiratory Diseases General Respiratory Diseases |
| subject_facet | Respiratory Diseases General Respiratory Diseases |
| title | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China |
| title_auth | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China |
| title_full | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China |
| title_fullStr | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China |
| title_full_unstemmed | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China |
| title_short | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China |
| title_sort | prospective observational real-world study of afatinib as first-line treatment in patients with epidermal growth factor receptor (egfr) mutation-positive advanced non-small cell lung cancer (nsclc) in china |
| topic | Respiratory Diseases General Respiratory Diseases |
| url | https://www.dovepress.com/prospective-observational-real-world-study-of-afatinib-as-first-line-t-peer-reviewed-fulltext-article-LCTT |